Roche Signs $2.8 Billion Alnylam Deal for Hypertension Drug
Roche Holding AG will work together with Alnylam Pharmaceuticals Inc. on a potential treatment for high blood pressure
2023-07-24 16:49
Astra, Sanofi RSV Drug Approved in US for Use in Infants
AstraZeneca Plc and Sanofi’s drug for RSV in infants was approved in the US, the first-ever preventive intended
2023-07-18 01:29
Chinese Province Saw Cremations Surge 73% as Covid Hit: Caixin
Cremations in one of China’s most populous provinces surged by 72.7% year-on-year in the first quarter, local media
2023-07-17 23:57
Lilly Applies for Alzheimer’s Drug’s US Approval After Trial Success
Eli Lilly & Co. said it applied for full US approval of its Alzheimer’s disease drug that’s expected
2023-07-17 22:45
Lilly to Pay Up to $2 Billion for Obesity Startup Versanis
Eli Lilly & Co. will acquire closely held Versanis Bio, a startup developing a drug for obesity and
2023-07-14 23:18
Eisai Appoints CEO’s 34-Year-Old Son to Lead Global Alzheimer Drug Program
Japanese drug giant Eisai Co. said global Alzheimer drug program officer Ivan Cheung will retire at the end
2023-07-11 09:46
Novo Weight Drugs Probed Over Reports of Suicidal Thoughts
Novo Nordisk A/S’s weight-loss medications are under investigation by the European Union’s drugs regulator after a small number
2023-07-10 20:18
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval
2023-07-07 08:46
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to
2023-07-07 05:29
Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Roivant Sciences Ltd. is attracting interest from large pharmaceutical companies for its treatment for inflammatory bowel disease, which
2023-07-07 03:21
New AstraZeneca Cancer Drug Shows Potential in Key Study
An AstraZeneca Plc cancer medicine showed a statistically significant improvement over standard chemotherapy in a high-level study. The
2023-07-03 14:54
Novartis Sells Eye Drugs to Bausch for Up to $2.5 Billion
Novartis AG agreed to sell part of its portfolio of eye medicines to Bausch + Lomb Corp. in
2023-06-30 20:53